Topical intranasal ioxaglate meglumine 39.3% and ioxaglate sodium 19.6% (Hexabrix) reduces the acute response to nasal challenge with allergen

✍ Scribed by Vishwanath, Shilpa; Baroody, Fuad M.; Chaaban, Mohamad R.; deTineo, Marcella; Lasser, Kenneth H.; Lasser, Elliot C.; Naclerio, Robert M.

• Book ID: 119285239
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 80 KB
• Volume: 128
• Category: Article
• ISSN: 1097-6825
• DOI: 10.1016/j.jaci.2011.02.024